1. Home
  2. TIVC vs CYCC Comparison

TIVC vs CYCC Comparison

Compare TIVC & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIVC
  • CYCC
  • Stock Information
  • Founded
  • TIVC 2016
  • CYCC 1992
  • Country
  • TIVC United States
  • CYCC United States
  • Employees
  • TIVC N/A
  • CYCC N/A
  • Industry
  • TIVC Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CYCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • TIVC Health Care
  • CYCC Health Care
  • Exchange
  • TIVC Nasdaq
  • CYCC Nasdaq
  • Market Cap
  • TIVC 1.8M
  • CYCC 1.8M
  • IPO Year
  • TIVC 2021
  • CYCC N/A
  • Fundamental
  • Price
  • TIVC $0.28
  • CYCC $0.36
  • Analyst Decision
  • TIVC
  • CYCC Buy
  • Analyst Count
  • TIVC 0
  • CYCC 2
  • Target Price
  • TIVC N/A
  • CYCC $11.00
  • AVG Volume (30 Days)
  • TIVC 16.2M
  • CYCC 3.7M
  • Earning Date
  • TIVC 11-14-2024
  • CYCC 11-12-2024
  • Dividend Yield
  • TIVC N/A
  • CYCC N/A
  • EPS Growth
  • TIVC N/A
  • CYCC N/A
  • EPS
  • TIVC N/A
  • CYCC N/A
  • Revenue
  • TIVC $957,000.00
  • CYCC $74,000.00
  • Revenue This Year
  • TIVC $324.15
  • CYCC N/A
  • Revenue Next Year
  • TIVC N/A
  • CYCC $16.28
  • P/E Ratio
  • TIVC N/A
  • CYCC N/A
  • Revenue Growth
  • TIVC N/A
  • CYCC N/A
  • 52 Week Low
  • TIVC $0.22
  • CYCC $0.35
  • 52 Week High
  • TIVC $3.21
  • CYCC $6.00
  • Technical
  • Relative Strength Index (RSI)
  • TIVC 47.33
  • CYCC 29.98
  • Support Level
  • TIVC $0.24
  • CYCC $0.35
  • Resistance Level
  • TIVC $0.45
  • CYCC $0.52
  • Average True Range (ATR)
  • TIVC 0.06
  • CYCC 0.07
  • MACD
  • TIVC 0.00
  • CYCC -0.01
  • Stochastic Oscillator
  • TIVC 12.12
  • CYCC 3.94

About TIVC Tivic Health Systems Inc.

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.

Share on Social Networks: